Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | EVP, Strategic & Corp. Devlp. | June 04, 2007 | June 05, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date June 04, 2007 · Filed June 05, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,273 |
Ending reported balance
After 2007-06-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2007-06-04 · Exercise / conversion · Acquired 3,000 · Balance 100,273 Row 2 · 2007-06-04 · Sale · Disposed 3,000 · Balance 97,273 F1: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $11.40 · Expires 2015-02-14 | Direct | 97,000 |
Reported balance
After 2007-06-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2007-06-04 · Exercise / conversion · Disposed 3,000 · Balance 97,000 F2: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. |
| Common StockSEC Table I · non-derivative | Indirectshares 401(k) | 1,111 |
Reported balance
Holding disclosure · report date 2007-06-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,111 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1.
F2: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2007 Filed Jun 5, 2007 16:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000067 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| June 04, 2007 Filed Jun 5, 2007 16:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $29.51 | $88,530.00 |
DisclosureSEC source: 0000875320-07-000067 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| June 04, 2007 Filed Jun 5, 2007 16:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000067 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2007 Filed May 21, 2007 19:26 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 824 | $31.95 | $26,326.80 |
DisclosureSEC source: 0000875320-07-000053 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 03, 2007 Filed May 4, 2007 15:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000042 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| May 03, 2007 Filed May 4, 2007 15:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $30.59 | $91,770.00 |
DisclosureSEC source: 0000875320-07-000042 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| May 03, 2007 Filed May 4, 2007 15:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000042 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 03, 2007 Filed Apr 4, 2007 17:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000034 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| April 03, 2007 Filed Apr 4, 2007 17:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $28.60 | $85,800.00 |
DisclosureSEC source: 0000875320-07-000034 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| April 03, 2007 Filed Apr 4, 2007 17:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000034 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000029 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $29.60 | $88,800.00 |
DisclosureSEC source: 0000875320-07-000029 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:41 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000029 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000021 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $32.76 | $98,280.00 |
DisclosureSEC source: 0000875320-07-000021 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:30 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000021 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 54,375 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0000875320-07-000016 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,375 Underlying: Common Stock · 54,375 shares Expires 2017-01-23 F3 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 01/24/2007. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 20,000 | $0.01 | $200.00 |
DisclosureSEC source: 0000875320-07-000016 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,273 F2 · shares: Stock grant made under 2006 Stock and Option Plan, vesting as to 5,000 shares on May 6, 2008, and as to 15,000 shares on May 6, 2010. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 12,084 | $0.01 | $120.84 |
DisclosureSEC source: 0000875320-07-000016 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,273 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 1/24/2011, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-07-000001 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,000 Underlying: Common Stock · 3,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $37.61 | $112,830.00 |
DisclosureSEC source: 0000875320-07-000001 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,189 F1 · kind: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:21 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 3,000 | $11.40 | $34,200.00 |
DisclosureSEC source: 0000875320-07-000001 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2006 Filed Aug 2, 2006 14:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 35,000 | $0.00 Strike: $11.40 | $0.00 |
DisclosureSEC source: 0000875320-06-000071 · edgar.xml · derivative · entry 4 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 35,000 shares Expires 2015-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/15/2005. Read SEC document |
| August 01, 2006 Filed Aug 2, 2006 14:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 48,000 | $32.31 | $1,550,880.00 |
DisclosureSEC source: 0000875320-06-000071 · edgar.xml · nonDerivative · entry 2 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,189 Read SEC document |
| August 01, 2006 Filed Aug 2, 2006 14:42 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 35,000 | $11.40 | $399,000.00 |
DisclosureSEC source: 0000875320-06-000071 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2006 Filed Jul 24, 2006 17:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 36,250 | $0.00 Strike: $35.35 | $0.00 |
DisclosureSEC source: 0000875320-06-000067 · edgar.xml · derivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,000 Underlying: Common Stock · 36,250 shares Expires 2016-07-19 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/20/2006. Read SEC document |
| May 17, 2006 Filed May 18, 2006 16:10 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 951 | $31.46 | $29,918.46 |
DisclosureSEC source: 0000875320-06-000044 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,189 F1 · shares: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 16, 2006 Filed Feb 17, 2006 14:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 6,312 | $36.94 | $233,165.28 |
DisclosureSEC source: 0000875320-06-000020 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,189 F1 · shares: Transaction made pursuant to Dr. Hartmann's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 108,750 | $0.00 Strike: $35.64 | $0.00 |
DisclosureSEC source: 0000875320-06-000015 · edgar.xml · derivative · entry 3 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,750 Underlying: Common Stock · 108,750 shares Expires 2016-02-01 F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/02/2006. Read SEC document |
| February 02, 2006 Filed Feb 6, 2006 21:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 14,501 | $0.01 | $145.01 |
DisclosureSEC source: 0000875320-06-000015 · edgar.xml · nonDerivative · entry 1 Hartmann Victor A · CIK 0001317101 · EVP, Strategic & Corp. Devlp. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,501 F1 · shares: Stock grant made under 1996 Stock and Option Plan, vesting on 2/2/2010, subject to acceleration upon achievement of certain performance-based milestoned. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.